{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:23:52Z","timestamp":1790277832986,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.jneuroim.2016.02.006","type":"journal-article","created":{"date-parts":[[2016,2,15]],"date-time":"2016-02-15T15:47:37Z","timestamp":1455551257000},"page":"65-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Increased occurrence of anti-AQP4 seropositivity and unique HLA Class II associations with neuromyelitis optica (NMO), among Muslim Arabs in Israel"],"prefix":"10.1016","volume":"293","author":[{"given":"Livnat","family":"Brill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha","family":"Mandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Karussis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panayiota","family":"Petrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keren","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamir","family":"Ben-Hur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon","family":"Karni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ora","family":"Paltiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoshana","family":"Israel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Vaknin-Dembinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2016.02.006_bb0005","doi-asserted-by":"crossref","first-page":"e79649","DOI":"10.1371\/journal.pone.0079649","article-title":"Neuromyelitis optica in Austria in 2011: to bridge the gap between neuroepidemiological research and practice in a study population of 8.4 million people","volume":"8","author":"Aboul-Enein","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000085556","article-title":"Epidemiology of multiple sclerosis in Kuwait: new trends in incidence and prevalence","volume":"53","author":"Alshubaili","year":"2005","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0015","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/gene.2010.20","article-title":"Opposing effects of the HLA-DRB1*0301-DQB1*0201 haplotype on the risk for multiple sclerosis in diverse Arab populations in Israel","volume":"11","author":"Benedek","year":"2010","journal-title":"Genes Immun."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0020","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s00415-009-5171-x","article-title":"Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution","volume":"256","author":"Bizzoco","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0025","first-page":"146","article-title":"HLA-DRB1 typing in Caucasians patients with neuromyelitis optica","volume":"53","author":"Blanco","year":"2011","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/1352458509350741","article-title":"HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis","volume":"16","author":"Brum","year":"2010","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0035","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1212\/WNL.56.4.507","article-title":"MS and neuromyelitis optica in Martinique (French West Indies)","volume":"56","author":"Cabre","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0040","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/1352458510382810","article-title":"Different HLA class II (DRB1 and DQB1) alleles determine either susceptibility or resistance to NMO and multiple sclerosis among the French Afro-Caribbean population","volume":"17","author":"Deschamps","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0045","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jbspin.2005.09.001","article-title":"Genetic basis of rheumatoid arthritis","volume":"72","author":"Dieude","year":"2005","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0050","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1007\/s00415-006-0203-2","article-title":"Multiple sclerosis in Jordan: a clinical and epidemiological study","volume":"253","author":"El-Salem","year":"2006","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0055","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2337\/db07-1331","article-title":"HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families","volume":"57","author":"Erlich","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0060","first-page":"174720","article-title":"Epidemiology of neuromyelitis optica in the world: a systematic review and meta-analysis","volume":"2015","author":"Etemadifar","year":"2015","journal-title":"Mult. Scler. Int."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0065","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-065X.2012.01134.x","article-title":"The genetics of multiple sclerosis: an up-to-date review","volume":"248","author":"Gourraud","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2015.06.010","article-title":"The immunogenetics of multiple sclerosis: a comprehensive review","author":"Hollenbach","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0075","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jns.2012.08.032","article-title":"Increased prevalence, incidence, and female predominance of multiple sclerosis in Northern Japan","volume":"323","author":"Houzen","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0080","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1212\/WNL.0000000000000683","article-title":"Inflammatory neurologic disease in sub-Saharan Africa","volume":"83","author":"Howlett","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0085","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0198-8859(98)00074-3","article-title":"HLA class II immunogenetics of IDDM in Yemenite Jews","volume":"59","author":"Israel","year":"1998","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0090","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1007\/s00415-013-6926-y","article-title":"The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United Kingdom","volume":"260","author":"Jacob","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0095","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/cei.12271","article-title":"Neuromyelitis optica: clinical features, immunopathogenesis and treatment","volume":"176","author":"Jarius","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0100","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF00868444","article-title":"Multiple sclerosis: genetic versus environmental aetiology: epidemiology in Israel updated","volume":"241","author":"Kahana","year":"1994","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0105","first-page":"410","article-title":"Evidence for the genetic role of human leukocyte antigens in low frequency DRB1*1501 multiple sclerosis patients in Israel","volume":"5","author":"Karni","year":"1999","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0110","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000067101","article-title":"The frequency of multiple sclerosis in jewish and arab populations in greater Jerusalem","volume":"22","author":"Karni","year":"2003","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0115","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s00415-012-6441-6","article-title":"Incidence of acquired demyelinating syndromes of the CNS in Dutch children: a nationwide study","volume":"259","author":"Ketelslegers","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0120","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1212\/WNL.0b013e31824f8069","article-title":"Clinical spectrum of CNS aquaporin-4 autoimmunity","volume":"78","author":"Kim","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0125","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1471-2377-14-93","article-title":"Characterization of the spectrum of Korean inflammatory demyelinating diseases according to the diagnostic criteria and AQP4-Ab status","volume":"14","author":"Kim","year":"2014","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1474-4422(03)00308-9","article-title":"Multiple sclerosis in the Japanese population","volume":"2","author":"Kira","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0135","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S1474-4422(10)70064-8","article-title":"The changing demographic pattern of multiple sclerosis epidemiology","volume":"9","author":"Koch-Henriksen","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0140","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0145","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.autrev.2006.02.008","article-title":"Neuromyelitis optica \u2014 Devic's syndrome, update","volume":"5","author":"Mandler","year":"2006","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0150","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0002-9297(07)64074-9","article-title":"Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and -DR4 alleles","volume":"61","author":"Marrosu","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0155","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1212\/WNL.0b013e3181ea9f15","article-title":"Familial neuromyelitis optica","volume":"75","author":"Matiello","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0160","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1399-0039.2008.01172.x","article-title":"Association of the HLA-DPB1*0501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders","volume":"73","author":"Matsushita","year":"2009","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0165","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/archneurol.2012.314","article-title":"Epidemiology of neuromyelitis optica in the United States: a multicenter analysis","volume":"69","author":"Mealy","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0170","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mam.2014.12.004","article-title":"Immunogenetics of type 1 diabetes mellitus","volume":"42","author":"Morran","year":"2015","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0175","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ajhb.22610","article-title":"Continuous decrease of consanguineous marriages among Arabs in Israel","volume":"27","author":"Na'amnih","year":"2015","journal-title":"Am. J. Hum. Biol."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0180","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/1352458508098372","article-title":"Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30years","volume":"15","author":"Osoegawa","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0185","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1177\/1352458514521503","article-title":"Prevalence and patterns of demyelinating central nervous system disorders in urban Mangalore, South India","volume":"20","author":"Pandit","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0190","doi-asserted-by":"crossref","DOI":"10.1177\/1352458515572406","article-title":"Demographic and clinical features of neuromyelitis optica: a review","author":"Pandit","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2015.05.034","article-title":"Epidemiological, clinical, and immunological characteristics of neuromyelitis optica: a review","author":"Pereira","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0200","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1177\/1352458512445059","article-title":"Multiple sclerosis in diverse populations: characteristics in distinct Arab ethnicities in Israel","volume":"18","author":"Siegel","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0205","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1212\/WNL.0b013e31822c61b1","article-title":"AQP4 antibody-positive Thai cases: clinical features and diagnostic problems","volume":"77","author":"Siritho","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0210","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/sj.gene.6363783","article-title":"Analysis of the association of HLA-DRB1, TNFalpha promoter and TNFR2 (TNFRSF1B) polymorphisms with SLE using transmission disequilibrium test","volume":"2","author":"Tsuchiya","year":"2001","journal-title":"Genes Immun."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0215","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1155\/2006\/586306","article-title":"NMO-IgG: a specific biomarker for neuromyelitis optica","volume":"22","author":"Weinshenker","year":"2006","journal-title":"Dis. Markers"},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0220","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0225","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0230","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000358218","article-title":"Combined screening for serum anti-nuclear and anti-aquaporin-4 antibodies improves diagnostic accuracy for distinguishing neuromyelitis optica from multiple sclerosis","volume":"72","author":"Wu","year":"2014","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0235","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jns.2008.02.009","article-title":"Clinical characteristics of multiple sclerosis in Lebanon","volume":"270","author":"Yamout","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0240","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/jnnp-2012-302925","article-title":"Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status","volume":"84","author":"Yoshimura","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2016.02.006_bb0245","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1177\/1352458508102085","article-title":"Is neuromyelitis optica associated with human leukocyte antigen?","volume":"15","author":"Zephir","year":"2009","journal-title":"Mult. Scler."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572816300285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572816300285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:27:26Z","timestamp":1759048046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572816300285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":49,"alternative-id":["S0165572816300285"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2016.02.006","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased occurrence of anti-AQP4 seropositivity and unique HLA Class II associations with neuromyelitis optica (NMO), among Muslim Arabs in Israel","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2016.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}